University of Guelph, Canada
Kailash C Chadha graduated from University of Guelph, Guelph, Ontario, Canada and completed his postdoctoral work as a fellow of National Research Council of Canada. He came to Roswell Park as Assistant Professor of Oncology in 1972 and later was promoted to Associate Professor of Oncology. He also holds a joint appointment as Research Assistant Professor in the Department of Medicine, the School of Medicine, State University of New York at Buffalo. His research interests are largely in the area of Interferons & Other Cytokines and role of Prostate Specific Antigen (PSA) in prostate cancer. Dr. Chadha has authored and co-authored more than 120 journal articles, several reviews and book chapters. He has also edited a book on Interferons and has four US Patents. He has also participated in several national and international meetings as an invited speaker.
National University of Singapore, Singapore
After completion of his postdoctoral training at University of Texas MD Anderson Cancer Center, Dr. Gautam Sethi joined Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore in 2008 as an Assistant Professor and was promoted to Associate Professor in 2015. The focus of his research over the past few years has been to elucidate the mechanism (s) of activation of oncogenic transcription factors such as NF-?B/STAT3 by carcinogens and inflammatory agents and the identification of novel inhibitors of these proteins for prevention of and therapy for cancer. The findings of his research work have so far resulted in more than two hundred and fifty scientific publications in high impact factor peer reviewed journals (with h index = 82) and several international awards. He currently serves as an Academic Editor for PLOS, editorial board member of Cancer Letters, Scientific Reports, Pharmacological Research, World Journal of Pharmacology, BMC Cancer, Frontiers in Pharmacology, Frontiers in Oncology, International Journal of Biological Sciences, Journal of Functional Foods, Journal of Natural Products in Cancer Prevention and Therapy, and ad-hoc reviewer for several other prestigious international journals.
University of Cambridge, UK
Dr Sorush Niknamian is a Professional Biologist, Senior Research Scientist, Chartered Scientist and Registered. His Science Council ID is: A-0008833. He is one of United Kingdom and Indiana Cancer Consortium (ICC) certified. He is a Registered Researcher in the U.S. Government's System for Award Management, Registered Scientist at National Center for Biotechnology Information. He is studying Medicine/Military Medicine at Liberty University (LU), Lynchburg, VA, United States of America. He holds Bachelor’s Degree in Mechatronics Engineering, applied Mathematics, Civil Engineering and Management. He is an Honorary Board Member and contributor of Weston A Price. Foundation (WAPF) in Washington DC, United States of America. He Holds Honorary Doctorate of Cancer Biology and Doctor of Science from Violet Cancer Institute. He is an ACP Chapter member in United States Army and Air Force. Active Member of IMRTC-USA as Advisor, Referee and Professor at IMRTC-USA. He is a Service Member of Modern Military Association of America & Certified Member of World Medical Association with ID: 5c7b154b01602 as a Junior Medical Doctor. He is an Active Member of the National Guard Association of the United States of America & Serving Volunteer at the Peace Corps of the United States of America (Ref ID: 10811430) and certified member of The National Bureau of Asian Research. He is a member of Military Officers Association of America. He is one of the certified member of Texas Section of the American Physical Society, active Member of the United Nation. He is a Certified and professional in Terrorism Affairs, Terrorism Analysis and Terrorism Counterterrorism from American Military University (AMU). He has written more than 30 books in different area of science specially Medicine, Evolutionary Biology, Nutrition and Oncology. He has published more than 120 research articles in International and National scientific journals.
Universitat deValència, Spain
Francisco Torrens is lecturer in physical chemistry at the Universitat deValència. After obtaining a PhD in molecular associations in azines and macrocycles from the Universitat deValència, Dr. Torrens undertook postdoctoral research with Professor Rivail at the Université de Nancy I. More recently, Dr. Torrens has collaborated on projects with Professors Tomás-Vert, Salgado and Castellano. Major research projects include prediction of the environmental impact of chemical substances using chemobioinformatics tools, discovery of new inhibitors of tyrosinase: computational design, synthesis, characterization and experimental corroboration, search for new antimicrobial agents that inhibit the synthesis of the bacterial cell wall, minimal active domains of proteins of the Bcl 2 family, development and application of quantum chemistry methods and techniques to studies of drugs, analysis of pores of BAX at nanometric scale and study of the in vivo antioxidant capacity of phenolic compounds through QSAR/QSPR modelling: crossing of the blood-brain barrier and interactions with cytochromes and drugs. His scientific accomplishments include the first implementation in a computer at the Universitat deValència of a program for the elucidation of crystallographic structures and the construction of the first computational-chemistry program adapted to a vector-facility supercomputer in a Spanish university.
MAHSA University, Malaysia
Gopal Natesan has completed his Doctoral degree (PhD) in Pharmaceutical Chemistry from Hamdard University (Jamia Hamdard) New Delhi, India in 2000 and currently serving as Professor of Medicinal Chemistry & Deputy Dean of Research & Innovation and Students Affairs in Faculty of Pharmacy, MAHSA University, Kuala Lumpur, Malaysia. His research focuses on the synthesis of newer small chemical entities, quinazolinones heterocyclic pharmacophore and their preliminary screening in both in-vivo and in-vitro models mainly focusing on pain & inflammation and also for newer microbial agents. He has published > 40 articles in indexed journals and presented > 80 papers at conferences and invited speaker at international scientific meetings and conferences and serves as reviewer for several scientific international journals and also as Editorial/Advisory board of various journals.
Chinese University of Hong Kong, Hong Kong
Chen Yangchao is currently an Associate Professor at School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK). He obtained his Ph.D. from Sun Yat-sen University in 2003 and later on was trained as a postdoctoral fellow at University of Washington, Seattle. He has been faculty member as Research Assistant Professor, Assistant Professor and Associate Professor at Faculty of Medicine CUHK since 2007. His research interests include epigenetics in cancer, histone modification particularly methylation, long and short non-coding RNAs, development of novel therapeutics for liver and pancreatic cancer. The ultimate goal of his lab is aimed at the identification of novel diagnostic markers and therapeutic targets for pancreatic and liver cancer.